This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Nvidia‘s (NASDAQ: NVDA) graphics processing units (GPUs) for data centers are the gold standard for developing artificial intelligence (AI) models. Demand continues to exceed supply for these chips, as the world’s largest tech giants battle for supremacy in the emerging AI industry.

By 2030, Nvidia CEO Jensen Huang estimates data center operators will be spending up to $4 trillion annually on infrastructure to meet demand from AI developers, and a sizable chunk of that money will go toward GPUs.

Nvidia stock has soared more than tenfold since the beginning of 2023, which is when the AI boom started gathering momentum, but it’s still trading at a very attractive valuation. The stock is priced at $181 as I write this, but here’s why I predict it will breeze past $300 in 2026. 

Nvidia will launch its most powerful GPUs ever in 2026

GPUs are designed for parallel processing, meaning they can handle multiple tasks simultaneously which makes them ideal for data-intensive AI workloads. Nvidia’s GPU architectures (the latest of which is called Blackwell Ultra) are optimized specifically for AI, and it currently leads the industry in terms of performance.

Blackwell Ultra-based GB300 GPUs produce up to 50 times more processing power in certain configurations compared to Nvidia’s original Hopper-based H100 chips from 2022, which highlights how far the company has come in just three years.

The H100 was perfect for one-shot large language models (LLMs) like OpenAI’s GPT-3 and Alphabet‘s Gemini 1 from a few years ago, but each new generation of AI model requires more computing capacity. In fact, Nvidia CEO Jensen Huang says the latest reasoning models — like GPT-5.1 and Gemini 3 — consume up to 1,000 times more tokens (words and symbols), so even Blackwell Ultra GPUs aren’t necessarily enough.

But Nvidia plans to take an enormous leap forward in 2026 by launching its new Rubin architecture. It’s expected to be around 3.3 times more powerful than Blackwell Ultra, which implies a staggering 165 times performance increase over Hopper. Nvidia is already experiencing more demand than it can possibly supply for its current chips, and Rubin will probably accentuate that imbalance, giving the company incredible pricing power.

Record revenue is forecasted for next year

According to management’s guidance, Nvidia is on track to generate a record $212 billion in total revenue during its current fiscal 2026 year (which ends on Jan. 31, 2026). Almost 90% of that revenue will come from the data center segment alone, which highlights the importance of GPU sales.

Wall Street’s consensus estimate (provided by Yahoo! Finance) shows that Nvidia’s revenue could soar by 48% to $313 billion in fiscal 2027 (which starts in February 2026). Analysts also predict the company’s earnings could surge by 59% year over year to $7.46 per share, which could have an extremely positive impact on its stock. I’ll discuss this further in a moment.

Nvidia has made a habit of beating its own forecasts and Wall Street’s estimates over the last couple of years, because demand for its AI GPUs has consistently been far stronger than expected. With the Rubin architecture in the pipeline, that dynamic is unlikely to change over the next 12 months.

Nvidia stock looks cheap

Based on Nvidia’s adjusted (non-GAAP) trailing 12-month earnings of $4.05 per share, its stock is trading at a price-to-earnings (P/E) ratio of 45.1. That’s a steep discount to its 10-year average of 61.2. If we use Wall Street’s fiscal 2027 earnings estimate of $7.46 per share, that places Nvidia stock at an even more attractive forward P/E ratio of 24.4:

NVDA PE Ratio data by YCharts

That means Nvidia stock would have to climb by 84% next year just to maintain its current P/E ratio of 45.1, and it would have to soar by a whopping 151% to trade in line with its 10-year average P/E ratio of 61.2. That would place the stock at somewhere between $334 and $454.

That being said, there are no guarantees in the stock market, especially in industries that move as fast as AI. Nvidia is facing growing competition from other chip makers, and also from tech giants like Alphabet, which are now training their AI models using their own specially designed chips.

This won’t be a near-term problem for Nvidia if Huang is right about AI infrastructure spending reaching $4 trillion annually by 2030, because it means demand for data center GPUs is likely to outstrip supply for the next several years.

However, Nvidia investors should keep a close eye on the competitive landscape in the new year, because if the company does experience declining demand, it could struggle to meet Wall Street’s revenue and earnings estimates, negatively impacting its stock.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Prediction: Nvidia stock is going to soar past $300 in 2026 appeared first on The Motley Fool Australia.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

More reading

• How to invest your first $1,000 in the share market the smart way
• Prediction: This AI stock will be the most surprising winner of 2026
• 3 ASX ETFs I’d buy right now to build wealth
• Here’s why Nvidia still is a multimillionaire-maker
• Amazon is expanding its AI chip ambitions. Should Nvidia investors be worried?

Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet and Nvidia. The Motley Fool Australia has recommended Alphabet and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The team at Macquarie have run the ruler over the mid-cap energy sector, and there’s one company they say stands out from the crowd.

Macquarie analysts are tipping a 41% increase in the share price of Amplitude Energy Ltd (ASX: AEL), forecasting the shares will hit $4, up from $2.84 at the time of writing their report.

They say the market is “risking the exploration program too heavily and we are particularly encouraged by the recent ConocoPhillips discovery at Essington-1”.

That refers to a new offshore gas discovery announced by ConocoPhillips last month, which spurred significant interest in the shares of its joint venture partner 3D Energi Ltd (ASX: TDO).

ConocoPhillips owns a 51% stake in the project and is the project operator, while Korea National Oil Company owns a 21% stake, and 3D owns a 20% stake.

The Australian company said in a statement to the ASX at the time that the Essington-1 drilling program had intersected two gas bearing reservoirs, with one having 58.5 metres of net gas pay while the second had 31.5 metres.

Cashed up for growth

Amplitude Energy has its own exploration program on the cards, as Chair John Conde told the company’s recent annual general meeting:

A few weeks ago we announced the proposed expansion of the East Coast Supply Project through an intended fourth well at the Nestor prospect. This expansion will maximise utilisation of our existing Otway Basin infrastructure and available processing capacity at the Athena Gas Plant, creating flexibility to supply gas during periods of high demand and pricing, including for gas-powered electricity generation.

Mr Conde said the engineering and drilling regulatory approvals for the Nestor drilling were already in place, and together with its joint venture partner, OG Energy, the company was working towards making a final investment decision in early calendar 2026.

To fund this and other growth opportunities, such as the potential restart of the Patricia Baleen field in the Gipplsand Basin, our company completed a $150 million equity raising in mid-October. We are very pleased with the level of demand shown for the equity raising, including from several new institutional investors and of course, from many of our loyal shareholders.   

Amplitude Energy was valued at $872.9 million at the close of trade on Friday.

Among other energy stocks, Macquarie has a neutral rating on Karoon Energy Ltd (ASX: KAR) and a neutral rating on Strike Energy Ltd (ASX: STX).

The post Which energy company is Macquarie tipping for a 41% share price rise? appeared first on The Motley Fool Australia.

More reading

• 4 reasons to buy this surging ASX 300 energy share today
• 5 things to watch on the ASX 200 on Friday
• This surging ASX energy stock is tipped to storm another 42% higher
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Premier Investments Ltd (ASX: PMV) shares have been having a tough time in 2025.

Since the start of the year, the retail giant’s shares are down almost 40%.

Things have been so bad, that the Peter Alexander and Smiggle owner’s shares hit a fresh 52-week low of $14.96 on Monday.

Is this a buying opportunity for investors? Let’s see what analysts at Macquarie Group Ltd (ASX: MQG) are saying.

What is the broker is saying?

Macquarie was disappointed with Premier Investments’ trading update at its annual general meeting and appears concerned that the poor form could continue. It said:

Disappointed expectations, falling -15% below VA Consensus expectations, and implying -7% decline y/y. PMV noted ‘discretionary spending remains under pressure with consumers cautious due to ongoing cost-of-living impacts’. ABS data indicates that monthly spending grew +3.5% MoM (+6.4% YoY), and Overall Discretionary improved +1.6% MoM (+5.1% YoY) in Oct-25. Further, our High Frequency Consumer Data also indicates that discretionary consumer spend is not declining.

We think the quantum of Smiggle’s expected decline (MRE: -15% y/y) suggests continuing product weakness + share loss. We also question whether Peter Alexander is still maintaining the ~9% sales growth at the Aug-25 result, with our forecasts now expecting a moderation to +5% growth for 1H26E, implying a deterioration over Sep-Nov-25.

Should you buy Premier Investments shares?

While the broker acknowledges that Premier Investments shares look cheap on paper, it is recommending investors keep their powder dry until its next update. Macquarie said:

We think the market has priced-in zero earnings for Smiggle, with the PMV valuation effectively reflecting the value of its BRG stake (A$6.93 per share), and Peter Alexander (A$9.24 per share). However, we reiterate Neutral, and look to the next disclosure of PA Segment LFL performance to gain confidence that earnings weakness is contained only to Smiggle.

According to the note, Macquarie has retained its neutral rating with a heavily reduced price target of $16.20 (from $20.80).

Commenting on its neutral rating, the broker said:

Neutral, but with improving risk/reward symmetry + upside-catalyst rich FY26e. Macro tailwinds to Australian consumption balanced and growth in Peter Alexander offset by headwinds to Smiggle from trading weakness.

Catalysts: Successful launch of capital-light, points-based PA loyalty program (Oct-25), Stronger Smiggle & UK trading over Christmas (Jan-26 update), M&A using Net Cash (MRE: ~FY27E+), Smiggle leadership appointment (Untimed).

The post What’s Macquarie’s price target on Premier Investments shares? appeared first on The Motley Fool Australia.

More reading

• Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today
• Why are Premier Investments shares crashing 12% today?
• Macquarie names best and worst ASX stocks to buy in a rising interest rate environment
• 3 ASX shares that I think are buys for both growth and dividends
• 1 ASX dividend stock down 25% that I’d buy right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The All Ordinaries Index (ASX: XAO) is down 0.2% today, but that’s not holding back this surging All Ords ASX rare earths share.

The outperforming miner in question is American Rare Earths Ltd (ASX: ARR).

American Rare Earths shares closed on Friday trading for 39 cents. In morning trade on Monday, shares are swapping hands for 40.5 cents apiece, up 3.9%.

This sees the ASX rare earths share up 35% in 2025, with shares now having surged 68.8% since the recent closing lows of 24 cents on 8 July.

Here’s what’s catching investor interest today.

All Ords ASX rare earths share gets a new CEO

This morning, American Rare Earths announced that Mark Wall would take the reins as CEO commencing on 5 January.

The ASX rare earths share noted that Wall has more than 30 years of global mining experience. This includes senior leadership roles with Tier 1 majors and North American developers, spanning operations, project development, permitting, and construction in gold, copper, diamonds, and uranium.

The company said that Wall’s track record in advancing complex projects is directly aligned with its transition from explorer to future US producer of rare earths elements.

Commenting on Wall’s appointment, American Rare Earths chair Richard Hudson said, “I am very pleased to have Mark lead this company forward.”

Hudson added:

He brings Tier 1 major mining pedigree, global capital markets leadership and deep North American experience, making him uniquely positioned to accelerate the company’s transformation and deliver value for shareholders as America’s secure supplier of rare earth elements.

Commenting on his appointment, Wall said, “American Rare Earths is at a genuinely transformative point in its journey.”

Wall continued:

The team has delivered substantial progress at Halleck Creek on resources, metallurgy and permitting, and I see a clear pathway from today’s studies through to demonstration plant, project financing and, ultimately, commercial production.

With growing US policy support for domestic critical minerals and our strong position in Wyoming, we have an opportunity to build a long life, sustainable rare earth business that contributes meaningfully to North American supply chain security.

What’s been happening with American Rare Earths?

The ASX rare earths share has been catching plenty of attention as the West ramps-up efforts to secure critical rare earths elements outside of China’s control.

The company’s flagship Halleck Creek project, located in the US state of Wyoming, recently saw a significantly upgraded mineral resource estimate for the Cowboy State Mine.

American Rare Earths said it is now advancing a pre-feasibility study, planning a demonstration plant, and evaluating a future US listing. Wall will play a crucial role in ensuring this success.

The post Up 69% since July, guess which All Ords ASX rare earths share is leaping higher today on major leadership news appeared first on The Motley Fool Australia.

More reading

• Which energy company is Macquarie tipping for a 41% share price rise?
• What’s Macquarie’s price target on Premier Investments shares?
• Why is this ASX AI share jumping 11% today?
• APA Group gains $1bn extra funding capacity after S&P credit rating change
• National Storage shares up as board recommends takeover bid

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Artrya Ltd (ASX: AYA) shares are starting the week with a bang.

In morning trade, the ASX AI share is up over 11% to $3.85.

Why is this ASX AI share jumping?

Investors have been bidding the company’s shares higher today after it secured its second customer in the United States.

According to the release, Artrya, which is a medical technology company commercialising its Salix AI-powered cloud platform, has signed a commercial agreement with Northeast Georgia Health System.

Management believes this marks another significant milestone in the company’s accelerating U.S. expansion strategy.

The Salix AI-powered cloud platform is used for the near real time, point of care assessment and management of coronary artery disease.

The release notes that the three-year commercial agreement has a minimum value of US$0.3 million, with additional fee-per-scan revenue from the Salix Coronary Plaque module and, following FDA clearance, the Salix Coronary Flow module.

The Salix platform will be rolled out across Northeast Georgia Health System’s network of hospitals and used by its cardiology group, Georgia Heart Institute.

Commenting on the news, the ASX AI share’s co-founder and CEO, John Konstantopoulos, said:

We are proud to secure our second U.S. commercial customer through this three-year commercial agreement with Northeast Georgia Health System, a respected leader in patient care across the U.S. Southeast. This builds our longstanding partnership to validate Salix in their workflow, and we are excited to roll out Salix across the Northeast Georgia Health System network.

We remain on track to convert all three U.S. foundation partners to commercial customers this year, where our new Customer Success team is already playing a leading role in integration and support.

Georgia Heart Institute’s chief cardiology officer, Mudassar Ahmed, MD, MBA, spoke positively about the deal, commenting:

The Salix platform will now go live in our clinical workflow, which represents an important step forward in how we deliver cardiovascular care. At Georgia Heart Institute, we are committed to adopting technologies that not only enhance diagnostic precision but also transform the patient journey. Through our work during the past two years, we have seen that Salix can bring a new dimension to our practice by supporting earlier identification of risk and enabling more proactive treatment strategies.

To support its growing U.S. customer base and anticipated expansion, the ASX AI share has established a customer success team in Atlanta. It notes that this team will serve as a technology and support hub, providing technical integration expertise, clinician engagement, and comprehensive customer support on the ground.

The post Why is this ASX AI share jumping 11% today? appeared first on The Motley Fool Australia.

More reading

• These 2 ASX small-cap shares have big potential for returns

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The APA Group (ASX: APA) share price is in focus today after S&P Global Ratings reaffirmed its BBB credit rating and improved APA’s debt threshold, enabling over $1 billion in extra growth funding.

What did APA Group report?

• S&P affirmed APA’s BBB (stable) long-term credit rating
• S&P lowered APA’s downside FFO to Debt threshold from 9.5% to 8.5%
• The modification increases debt capacity by more than $1 billion
• APA maintains stable and predictable cash flows
• The change strengthens APA’s ability to fund future growth projects

What else do investors need to know?

The adjustment from S&P recognises APA’s consistent cash generation and solid financial management. By lowering the downside threshold, APA can now take on additional debt to pursue expansion across its $27 billion portfolio of infrastructure assets.

APA supplies about half of Australia’s domestic gas through its 15,000 kilometres of pipelines and operates a mix of gas, electricity, wind, and solar assets nationally. This strengthened balance sheet supports the company’s strategy of securing Australia’s energy future.

What did APA Group management say?

CEO and Managing Director Adam Watson said:

It is pleasing to see S&P acknowledge the high-quality of our ongoing cashflows. S&P’s modification of our FFO to debt downside threshold is significant, providing more than $1 billion in additional funding capacity from our existing balance sheet.

We have strong momentum in the delivery of our growth strategy and remain focussed on efficient and prudent capital allocation to capture value from the most attractive long-term opportunities for APA securityholders. This ratings modification will provide further funding support for our attractive growth projects.

What’s next for APA Group?

APA is expected to use this enhanced debt capacity to fund new projects across its key energy infrastructure networks. The company remains focused on efficient investment and pursuing growth opportunities that can deliver value for securityholders.

As the transition to renewable energy accelerates and demand for reliable energy infrastructure grows, APA aims to maintain its strong financial position to support the nation’s evolving energy needs.

APA Group share price snapshot

APA Group shares have risen 27% over the past 12 months, outperforming the S&P/ASX 200 Index (ASX: XJO) which has increased 2% over the same period. 

View Original Announcement

The post APA Group gains $1bn extra funding capacity after S&P credit rating change appeared first on The Motley Fool Australia.

More reading

• DigiCo Infrastructure REIT appoints new CEO and sets strategic growth path
• Telix Pharmaceuticals updates investors as first patient is dosed in Phase 3 prostate cancer trial
• National Storage REIT agrees to $4bn Brookfield-GIC buyout: What it means for investors
• Corporate Travel Management and Boss Energy shares dumped from ASX 200
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Apa Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Shares in National Storage REIT (ASX: NSR) are trading higher on Monday after the company’s board said it would back a private equity-led takeover for the company.

National Storage, in late November, was forced to reveal that it was in takeover talks with Brookfield Property Group and GIC Investments after an article alluding to the deal was published by The Australian.

Bid now recommended by board

At the time, the then potential bid was “non-binding, indicative and conditional”; however, the NSR board on Monday said it would back the bid in the absence of a superior offer.

As the company said in a statement to the ASX:

The board of NSR unanimously recommends that NSR securityholders vote in favour of the transaction, in the absence of a superior proposal and subject to the independent expert concluding in the independent expert’s report (and continuing to conclude) that the transaction is in the best interests of NSR securityholders. Subject to the same qualifications, each NSR director intends to vote all NSR stapled securities controlled or held by them in favour of the transaction resolutions.

National Storage chair Anthony Keane said the board believed the transaction provided an attractive valuation and certainty for shareholders.

As he said:

The offer from the consortium follows a number of earlier offers and a period of negotiation. The decision to recommend this offer follows extensive work by the NSR board and its advisers to assess the fundamental value of NSR and its medium-to-long term prospects. Accordingly, the NSR board is unanimous in its recommendation that the transaction represents a compelling outcome for NSR securityholders.  

Shareholders in NSR will receive $2.86 per share, which will be reduced by 6 cents per share if the company pays out a dividend of that amount before the deal goes through.

Regulatory sign-off needed

The deal is subject to approval by the Foreign Investment Review Board and the New Zealand Office of Overseas Investment.

It will also need to be voted on by National Storage shareholders, with the meeting at which this vote is to take place likely to be held in April.

The deal is also subject to a break fee of $40 million should the consortium or National Storage decide to pull out of the transaction.

An independent expert’s report on the deal will now be completed and provided to shareholders before they are due to vote on the transaction.

National Storage shares were changing hands for $2.80 on Monday morning.

The post National Storage shares up as board recommends takeover bid appeared first on The Motley Fool Australia.

More reading

• National Storage REIT agrees to $4bn Brookfield-GIC buyout: What it means for investors
• These two takeover targets are still trading below their potential bid prices
• 3 ASX 200 shares smashing the benchmark this week
• This ASX storage REIT’s shares surge as takeover talks confirmed
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Telix Pharmaceuticals Ltd (ASX: TLX) shares are falling on Monday.

In morning trade, the ASX biotech stock is down 1% to $14.65.

What’s going on with Telix shares?

Telix shares are falling today despite the announcement from the radiopharmaceuticals company relating to its ProstACT Global Phase 3 study.

The company notes that ProstACT Global study is an international, multi-centre trial in two parts. Part 1 is a safety and dosimetry lead-in with 30 patients, whereas Part 2 is a 2:1 randomised global expansion with an overall target enrolment of approximately 490 patients.

The study is evaluating its lead prostate cancer therapy candidate TLX591 in patients with metastatic castration resistant prostate cancer (mCRPC).

According to the release, the first patient was dosed at the Australian Prostate Centre (APC) in Melbourne, Australia.

Management is optimistic about the future of TLX591. It highlights that it is the first phase 3 trial to combine a PSMA targeted radio antibody drug conjugate (rADC) therapy administered together with the standard of care versus the standard of care alone.

What’s next?

Telix has previously agreed with US Food and Drug Administration (FDA) that it will submit Part 1 data to enable clearance to expand Part 2 of the trial to U.S. sites.

A public disclosure of preliminary results from Part 1 of the study will be aligned to engagement with the FDA.

The study is also approved to commence in China, Japan, Singapore, South Korea, Turkey, and the United Kingdom. In addition, as part of the further global expansion of the trial, the company will file a clinical trial application (CTA) with the European Medicines Agency (EMA) to enable expansion into EU sites.

Commenting on the news, Telix’s group chief medical officer, Dr David N Cade, said:

Dosing the first patient into Part 2 of the randomized treatment expansion of ProstACT Global trial is a significant milestone for Telix’s late-stage prostate cancer therapeutics pipeline. We look forward to presenting the preliminary data from Part 1 of the study to the FDA and EMA in the coming months.

Should you invest?

While it has not yet responded to today’s news, the team at Bell Potter is bullish on Telix shares.

It currently has a buy rating and $23.00 price target on them, which implies potential upside of over 50% for investors based on its last close price.

The post Telix shares fall despite ‘significant milestone’ appeared first on The Motley Fool Australia.

More reading

• Telix Pharmaceuticals updates investors as first patient is dosed in Phase 3 prostate cancer trial
• These ASX innovators could be the market’s next big winners
• These are the 10 most shorted ASX shares
• Build significant wealth with these ASX growth shares over the next 10 years
• These are the 10 most shorted ASX shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.